News ArchivesRead News
In studies of human populations, don't believe everything you read
Thursday March 25, 2010
Los Angeles Times - All those studies linking broccoli, fiber, blueberries, wine, fat, sugar, this, that, with a greater or lower risk for cancer, heart disease, Parkinson's, Alzheimer's, headache, earache, you name it. Perhaps you sometimes wonder: How big of an effect are we talking about? Or even: Should I believe this?
If so, you might enjoy an NPR interview with Stanley Young, assistant director of bioinformatics at the National Institute of Statistical Sciences, that ran a few days ago.
The interview starts out with radio news segments -- not sure if they're real or mock-ups -- on two items that seem to come up often in media reports (the former especially around Valentine's Day): chocolate and coffee. ("People who eat dark chocolate have less heart disease." "People who drink coffee are less likely to develop Alzheimer's." Etcetera.)
The problem, Young says in the NPR interview, is if you collect lots of information about people's habits and number-crunch the bejabbers out of them, you'll find associations of some kind. And then, "If you can put a good story around the probably random finding that you found, you got a paper," he says.
The studies often end up in very reputable journals, he says. One of his favorite was a report -- published in the respected Proceedings of the Royal Society B -- that people who ate breakfast cereal in the morning around the time of conception were more likely to have baby boys than baby girls.
Young says the problem lies with observational studies -- the kind where you go into a population and collect information about the people's habits and diseases and such, then try to see what lifestyle factors are linked with what outcomes. Young's point is that many of the associations kicked up by such analyses are just plain random. (And even if they aren't, the associations certainly aren't proof of cause and effect, though that is not a point he makes in this interview.)
Much of the data scientists accumulate about human habits is of exactly this kind, because it's very expensive to conduct randomized clinical trials -- the kind where a group of people is randomly assigned to take either a drug or placebo and everything else is kept the same. You might see the money fall into place for a potential blockbuster drug -- not for broccoli, though.
Here's a technical paper of the issue as Young sees it, taken from a 2008 lecture he gave, which I accessed at his website. Among other things, he states: "The NIH has funded a large number of randomized clinical trials testing the claims coming from observational studies. Of 20 claims coming from observational studies only one replicated when tested in [randomized clinical trials]. The overall picture is one of crisis."
Here's a 2007 article we ran on the issue, written by freelance writer Andreas Von Bubnoff (Young is one of the scientists quoted in the article). In it, you'll see what epidemiologists have to say in defense of their science.
Recent NewsJul 7 - Parkinson’s Patients Have a Higher Risk of Developing Melanoma — and Vice Versa, Study Finds
Jun 27 - The rogue protein behind Parkinson’s disease may also protect your gut
Jun 26 - Do Statins Increase Risk of Parkinson’s Disease? Some Researchers Think So
Jun 22 - A Confused Immune System Could Be Behind Parkinson's Disease
Jun 21 - Predicting cognitive deficits in people with Parkinson’s disease
Jun 20 - Gym offers classes in noncontact boxing for Parkinson’s patients
Jun 19 - Human Limitations Could Prevent Us From Advancing in Science. AI Could Help.
Jun 13 - Brain Cell Transplants Are Being Tested Once Again For Parkinson's
Jun 12 - Smell Test May Sniff Out Oncoming Parkinson's and Alzheimer's
Jun 8 - Smartphones Track Motor Function in Parkinson's Disease
Jun 8 - GKC Enrolls First Patient in Personal KinetiGraph Trial as Part of NPF’s Parkinson’s Outcomes Project
Jun 8 - Low-fat dairy intake may raise Parkinson's risk
Jun 6 - Patient Voices: Parkinson's Disease
Jun 1 - World-First Trials Have Been Launched to Treat Parkinson's And Blindness With Embryonic Stem Cells
Jun 1 - LIFE Shared This Remarkable Parkinson's Disease Story in 1959.
May 24 - Survival Rates Differ Widely in Parkinson's, MSA, Lewy Bodies
May 22 - Discovery may offer hope to Parkinson's disease patients
May 15 - Study offers answers on life expectancy for people with Parkinson's disease, Lewy body dementia
May 5 - Parkinson's in a dish: Researchers reproduce brain oscillations
May 5 - ‘Hunger Hormone’ Could Help Treat Parkinson’s Disease